|
|
||||||||
Ann Thorac Surg 1993;55:25-31
© 1993 The Society of Thoracic Surgeons
a Georgetown University School of Medicine, Washington, DC USA
b Center for Devices and Radiological Health, Food and Drug Administration, Rockville, Maryland USA
* Address reprint requests to Dr Hopkins, Department of Surgery—4PHC, Georgetown University, 3800 Reservoir Road, NW, Washington, DC 20007.
Twenty-five human cryopreserved valves with harvest-related warm ischemic times (WITs) ranging from 0 to 20 hours were studied using transmission electron microscopy to characterize the effects of harvesting and preservation on leaflet matrix cells. The valves were divided into seven groups on the basis of WIT and processed using standard transmission electron microscopic methods. Each cell (528 micrographs) was graded for reversible and irreversible cellular injury and subjected to a Cochran-Mantel-Haenszel trend analysis. Our results demonstrated a progression in cellular injury with increasing WIT. During the first 12 hours of warm ischemia, reversible cellular injury predominated (0.0%, 30.0%, 51.2%, 31.3%, 35.1%, 45.1%, and 40.0% at WITs of 0, 1, 2, 8, 12, 16, and 20 hours, respectively). A positive correlation (p < 0.0001) between increasing WIT and reversible cellular injury through the first 12 hours was observed. Minimal morphologic evidence of irreversible injury was noted in valves harvested with less than 12 hours of warm ischemia; however, after 12 hours there was a marked increase (0.0%, 0.0%, 4.7%, 2.4%, 2.7%, 31.4%, and 40.0% at WITs of 0, 1, 2, 8, 12, 16, and 20 hours, respectively) in irreversible cellular injury (p < 0.001 between 12 and 20 hours WIT). These data demonstrate a progression in cellular injury with increasing WIT. There was virtually no morphologic injury in valves with harvest-related WITs less than 2 hours and minimal irreversible cellular injury observed in valves exposed to 12 hours or less of warm ischemia. If cellular viability is critical to homograft durability then harvest-related warm ischemia may need to be restricted to 12 hours.
This article has been cited by other articles:
![]() |
Y. C. Song, L. Y. Yao, J. M. Kneebone, and F. M. Lupinetti EFFECT OF CRYOPRESERVATION AND HISTOCOMPATIBILITY ON TYPE I PROCOLLAGEN GENE EXPRESSION IN AORTIC VALVE GRAFTS J. Thorac. Cardiovasc. Surg., September 1, 1997; 114(3): 421 - 427. [Abstract] [Full Text] |
||||
![]() |
C. Wassenaar, W. A. Bax, R.-J. van Suylen, V. D. Vuzevski, and E. Bos EFFECTS OF CRYOPRESERVATION ON CONTRACTILE PROPERTIES OF PORCINE ISOLATED AORTIC VALVE LEAFLETS AND AORTIC WALL J. Thorac. Cardiovasc. Surg., January 1, 1997; 113(1): 165 - 172. [Abstract] [Full Text] |
||||
![]() |
R. J. Baskett, D. B. Ross, M. A. Nanton, and D. A. Murphy FACTORS IN THE EARLY FAILURE OF CRYOPRESERVED HOMOGRAFT PULMONARY VALVES IN CHILDREN: PRESERVED IMMUNOGENICITY? J. Thorac. Cardiovasc. Surg., November 1, 1996; 112(5): 1170 - 1179. [Abstract] [Full Text] |
||||
![]() |
M. G. Hazekamp, D. R. Koolbergen, J. Braun, H. Sugihara, C. J. Cornelisse, Y. A. Goffin, and H. A. Huysmans In situ hybridization: A new technique to determine the origin of fibroblasts in cryopreserved aortic homograft valve explants J. Thorac. Cardiovasc. Surg., July 1, 1995; 110(1): 248 - 257. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |